Latest filing published 27 May 2021 for Neogenomics INC, €268k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +19.9%Entry US$7.69 · Close at T+365 US$9.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert J. Shovlin: trading record in brief
Robert J. Shovlin, listed as chief executive, appears in our data through filings on Neogenomics Inc shares, published by SEC (Form 4). We count 36 filings; the first trade dates from 3 December 2015 and the latest from 25 May 2021.
In open-market terms, that means 1 purchase worth €48k on one side and 12 sales worth €20.6M on the other. Sales outweigh purchases by €20.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 9 share grants and 14 option exercises. So far in 2021, the count stands at no purchases and 1 sale.
The latest filing, published on 27 May 2021, reports an option exercise of €268k in Neogenomics Inc. The most recent open-market purchase was published on 4 December 2015, 3,993 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert J. Shovlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,724 shares@ US$19.601.0% of flowCommon StockSEC:0001077183-21-000134:1
- 14,067 shares@ US$28.331.2% of flowCommon StockSEC:0001077183-21-000134:2
- 130,604 shares@ US$39.3115.3% of flowCommon StockSEC:0001077183-21-000134:3
- 96,167 shares@ US$8.03100.0% of flowCommon StockSEC:0001077183-21-000134:0
- 742 shares0Common StockSEC:0001077183-21-000082:0
- 608 shares0Common StockSEC:0001077183-21-000082:1
- 6,827 shares0Common StockSEC:0001077183-21-000082:2
- 66,667 shares@ US$7.524.1% of flowCommon StockSEC:0001077183-20-000171:0
- 16,724 shares@ US$19.602.7% of flowCommon StockSEC:0001077183-20-000171:1
- 81,356 shares@ US$38.1725.6% of flowCommon StockSEC:0001077183-20-000171:2
- 5,405 shares0Common StockSEC:0001077183-20-000116:0
- 96,167 shares@ US$8.036.8% of flowCommon StockSEC:0001077183-20-000047:0
- 98,093 shares@ US$30.8626.5% of flowCommon StockSEC:0001077183-20-000047:1
- 810 shares0Common StockSEC:0001077183-20-000035:0
- 8,736 shares0Common StockSEC:0001077183-20-000035:1
- 96,166 shares@ US$8.033.1% of flowCommon StockSEC:0001077183-19-000183:0
- 70,473 shares@ US$23.116.5% of flowCommon StockSEC:0001077183-19-000183:1
- 35,801 shares@ US$22.743.3% of flowCommon StockSEC:0001077183-19-000183:2
- 6,559 shares0Common StockSEC:0001077183-19-000098:0
- 66,666 shares@ US$7.151.9% of flowCommon StockSEC:0001077183-19-000058:0
- 66,667 shares@ US$7.522.0% of flowCommon StockSEC:0001077183-19-000058:1
- 52,680 shares@ US$22.144.6% of flowCommon StockSEC:0001077183-19-000058:2
- 66,667 shares@ US$22.145.9% of flowCommon StockSEC:0001077183-19-000058:3
- 10,944 shares0Common StockSEC:0001077183-19-000035:0
- 119,348 shares@ US$7.153.3% of flowCommon StockSEC:0001077183-19-000015:0
25 of 36 declarations
